AKAP8L antibody
Quick Overview for AKAP8L antibody (ABIN7467916)
Target
See all AKAP8L AntibodiesReactivity
Host
Clonality
Conjugate
Application
Grade
-
-
Specificity
- Knockdown/Knockout validation was supported by references (PMID:26990993)
-
Cross-Reactivity
- Human
-
Purification
- Purified by antigen-affinity chromatography.
-
Immunogen
- Recombinant protein encompassing a sequence within the center region of human AKAP8L. The exact sequence is proprietary.
-
Isotype
- IgG
-
-
-
-
Application Notes
- WB: 1:1000-1:10000. Optimal dilutions/concentrations should be determined by the researcher. Not tested in other applications.
-
Comment
-
Positive Control: 293T Validation: KO/KD
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- 0.1M Tris-Glycine ( pH 7), 20 % Glycerol, 0.01 % Thimerosal
-
Preservative
- Thimerosal (Merthiolate)
-
Precaution of Use
- This product contains Thimerosal (Merthiolate): a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- Store as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4°C. For long-term storage, aliquot and store at -20°C or below. Avoid multiple freeze-thaw cycles.
-
-
- AKAP8L (A Kinase (PRKA) Anchor Protein 8-Like (AKAP8L))
-
Alternative Name
- A-kinase anchoring protein 8 like
-
Background
-
Synonyms: A-kinase anchoring protein 8 like , HA95 , HAP95 , NAKAP , NAKAP95
Background: Could play a role in constitutive transport element (CTE)-mediated gene expression. Does not seem to be implicated in the binding of regulatory subunit II of PKA. May be involved in nuclear envelope breakdown and chromatin condensation. May regulate the initiation phase of DNA replication when associated with TMPO-beta.
-
Molecular Weight
- 72 kDa
-
Gene ID
- 26993
-
UniProt
- Q9ULX6
-
Pathways
- SARS-CoV-2 Protein Interactome
Target
-